Literature DB >> 23820338

Influence of additional criteria from a definition of cachexia on its prevalence--good or bad thing?

T Letilovic1, R Vrhovac.   

Abstract

BACKGROUND/
OBJECTIVES: Cachexia is a state of involuntary weight loss. The latest generic definition states that aside from weight loss, patient needs to fulfill additional criteria to be diagnosed with cachexia. New, condition-specific definitions also take the weight loss as a principal criterion, and additional criteria are not mandatory but are a part of further assessment. The aim of this study was to reveal the influence of additional criteria on the prevalence of cachexia in patients with various diseases linked to cachexia. Owing to this, we used the last generic definition. Possible differences in clinical presentations of patients with documented weight loss, with the respect of fulfillment of additional criteria were sought. SUBJECTS/
METHODS: Clinical and anthropometric data on 137 consecutive patients with malignant diseases and chronic heart failure from a single institution were collected.
RESULTS: Fourty-two (30.6%) patients had >5% weight loss in the last 12 months. Only 30 (21.8%) of them were found to meet additional three out of five criteria proposed by the new definition. This observed difference in the prevalence of cachexia diagnosed with or without using additional criteria was found to be significant (P=0.0006). Comparison of clinical/laboratory data showed significantly higher levels of C-reactive protein and lower levels of albumin, as well as lower measurements of mid-arm circumference, triceps and suprailiac skinfolds in patients that fulfilled additional criteria. Survival analysis did not show reduced survival of patients fulfilling additional criteria.
CONCLUSIONS: Additional criteria 'reduce' the prevalence of cachexia. They are indicative of differences in laboratory and clinical features of cachectic patients but do not influence their survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820338     DOI: 10.1038/ejcn.2013.121

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  5 in total

1.  Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.

Authors:  Michele Joana Alves; Raquel Galvão Figuerêdo; Flavia Figueiredo Azevedo; Diego Alexandre Cavallaro; Nelson Inácio Pinto Neto; Joanna Darck Carola Lima; Emidio Matos-Neto; Katrin Radloff; Daniela Mendes Riccardi; Rodolfo Gonzalez Camargo; Paulo Sérgio Martins De Alcântara; José Pinhata Otoch; Miguel Luiz Batista Junior; Marília Seelaender
Journal:  BMC Cancer       Date:  2017-03-14       Impact factor: 4.430

2.  The prevalence of deranged C-reactive protein and albumin in patients with incurable cancer approaching death.

Authors:  Sarah Gray; Bertil Axelsson
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

3.  An exploration of the prevalence and experience of cardiac cachexia: protocol for a mixed methods cross-sectional study.

Authors:  Matthew A Carson; Joanne Reid; Loreena Hill; Lana Dixon; Patrick Donnelly; Paul Slater; Alyson Hill; Donna Fitzsimons
Journal:  BMC Palliat Care       Date:  2019-10-20       Impact factor: 3.234

Review 4.  Cardiac cachexia: hic et nunc.

Authors:  Goran Loncar; Jochen Springer; Markus Anker; Wolfram Doehner; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-07-01       Impact factor: 12.910

5.  A Prospective Randomized Controlled Trial to Study the Impact of a Nutrition-Sensitive Intervention on Adult Women With Cancer Cachexia Undergoing Palliative Care in India.

Authors:  Neha Kapoor; Jane Naufahu; Sundus Tewfik; Sushma Bhatnagar; Rakesh Garg; Ihab Tewfik
Journal:  Integr Cancer Ther       Date:  2016-06-01       Impact factor: 3.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.